Tc99m tilmanocept is designed for the precise identification of lymph nodes that drain from a primary tumor, which have the highest probability of harboring cancer
Turn has developed a novel cell rejuvenating platform with significant potential for application in an array of age-related diseases
Highlighted as game changer in drug development & delivery special feature on innovative technologies for improving drug solubility and bioavailability
A growing portfolio of chemicals is part of a larger quality management system that sets new standards in bioprocessing
RNA, cell & gene therapies, artificial intelligence, CRISPR and oncology-related deals dominate the landscape
The study met its primary endpoint and showed equivalent efficacy and a comparable safety profile
Investment in technology and people and a meaningful industry-academia partnership can fuel the growth of the Indian biopharma sector
Meteoric Biopharmaceuticals have made rapid strides in the development of enzymes, probiotics and veterinary health products. It is seeking opportunities to scale up its growth backed by cutting edge R&D. Gaurav Kaushik, MD & CEO, Meteoric Biopharmaceuticals spoke to Thomas C Thottathil on the way forward
Thermo Fisher and Symphogen extend their collaboration using innovative and efficient workflows to improve data confidence, aiding the creation of new cancer treatments
Vonjo is the first approved therapy to specifically address the needs of adult cytopenic myelofibrosis patients
Subscribe To Our Newsletter & Stay Updated
